
460
Human Molecular Genetics, 1999, Vol. 8, No. 3
Further development of sensitive assays, such as bisulfite DNAsequencing (20) and methylation-specific PCR (21), has alloweda detailed analysis of multiple CpG sites across a CpG island ofinterest. These reductionistic approaches have yielded importantinformation regarding the local methylation control of individualgenes. As a further step toward a more comprehensive under-standing of the underlying mechanisms, it is necessary to conducta genome-wide analysis of de novo methylation in cancer. Suchan analysis can lead to the identification of previously unchar-acterized CpG islands associated with gene silencing and shedlight on other, as yet unidentified factors governing aberrantmethylation. With this in mind, we developed a DNA array-basedmethod, called differential methylation hybridization (DMH), toidentify hypermethylated sequences in tumor cells by simulta-neously screening many CpG island loci derived from a genomiclibrary, CGI (22). The method was applied to determine themethylation status of >276 CpG island loci in a group of breastcancer cell lines known to have increased DNA-MTase activities.This analysis, for the first time, presents a bird’s-eye view of CpGisland hypermethylation in the breast tumor genome and providesnew evidence that, aside from the aberrant DNA-MTase action,additional elements participate in this epigenetic process.RESULTS
Expression of the DNMT1 and p21WAF1 genes in breastcancer cells
Human cancer cells have increased DNA-MTase activities knownto promote CpG island hypermethylation during tumor progression(13,14,23). Since DNMT1 is primarily responsible for DNA-MTasesynthesis, we determined its mRNA levels in breast cancer cell linesT47D, ZR-75-1, Hs578t, MDA-MB-231, MDA-MB-468 andMCF-7. Northern analysis showed 3- to 12-fold higher levels of the5.4 kb DNMT1 mRNA in these cell lines compared with a normalcontrol sample (Fig. 1, upper panel). These results are consistentwith a previous study that showed both increases of DNMT1 mRNAlevels and the resulting elevation of DNA-MTase enzyme activitiesin the same cell lines (24).
Chuang et al. (15) recently have shown that the p21 proteinnegatively regulates targeting of DNA-MTase to the replication-associated protein proliferating cell nuclear antigen (PCNA). Theyproposed that the presence of p21 prevents DNA-MTase access toreplicating DNA, thereby impeding hypermethylation in normalcells, while loss or decreased expression of p21 in tumor cells mayfacilitate aberrant methylation. We, therefore, determined theexpression of the gene encoding p21 in these breast cancer cells. Theexpected 2.1 kb p21WAF1 transcript was detected in the cells lineswith levels 2- to 8-fold lower than the normal control sample (Fig.1, middle panel). This result, together with the DNMT1 finding,suggests that these breast cancer cell lines possess an increasedcapacity to methylate their genomes aberrantly.
Profiling methylation patterns in breast cancer cells byDMH
We developed DMH to determine the extent of CpG islandsequences undergoing de novo methylation in the six cancer celllines described above (Fig. 2). Genomic DNA from these cells wasfirst treated with the four-base frequent cutter MseI. This endo-nuclease restricts genomic DNA into small fragments (100–200 bpaverage), but its recognition sequence, TTAA, rarely occurs within
Downloaded from Figure 1. Northern hybridization analysis of DNMT1 and p21WAF1 geneexpression in breast cancer cell lines. Total RNA (20 µg) isolated from normalfibroblast (lane 1) and breast cancer cell lines, T47D (lane 2), ZR-75-1 (lane 3),Hs578t (lane 4), MDA-MB-231 (lane 5), MDA-MB-468 (lane 6) and MCF-7(lane 7), was subjected to northern analysis. The membrane was probed withhmg.oxfordjournals.orgDNMT1 (top panel), p21WAF1 (middle panel) and β-actin (bottom panel),respectively. The predicted sizes (kb) of the indicated transcripts werecalculated using the RNA MW I ladder (Boehringer Mannheim) as a standard.Band intensities were quantified with ImageQuant Software (MolecularDynamics) and the relative levels of DNMT1 and p21WAF1 mRNAs werenormalized with the expression level of β-actin in each sample lane.
GC-rich regions, leaving most CpG islands intact. Moreover, therestricted fragments were expected to match the MseI-digestedinserts originally used in the construction of the CGI genomic library(22). DNA from normal breast tissue was digested similarly. Thecleaved ends of the GC-rich fragments were ligated to linkers.Repetitive sequences such as the AluI and KpnI families wereremoved from the digests using a Cot-1 subtractive hybridization at Wuhan University on January 19, 2011
approach (25). Half of the subtracted DNA was treated further withmethylation-sensitive endonuclease BstUI, whose recognition se-quence, CGCG, occurs frequently within CpG islands but rarely inbulk DNA. This endonuclease was selected for the methylationanalysis because >80% of the CGI inserts contain BstUI sites (22).Both BstUI-digested and undigested control DNAs were used astemplates for linker-PCR. Genomic fragments containing unmethy-lated BstUI sites were cut and could not be amplified in the treatedsamples, whereas the same fragments were amplified in theundigested, control samples. Some fragments containing methylatedBstUI sites in the cells were protected from the digestion and wereamplified by linker-PCR. The PCR products designated as ‘MseI-pre-treated amplicons’ or ‘MseI–BstUI-pre-treated amplicons’ wereused as probes for screening hypermethylated sequences. CpGisland clones were pre-selected from the CGI library to contain
growth inhibitory functions and diminished expression in human breast cancer....Methylation profiling of twenty promoter-CpG islands of genes which may ...
phosphatase gene murated in human brain ,breast ,and prostate cancer[J]....Methylation profiling of twenty promoter CpG islands of genes which may ...
Methylation profiling of twenty promoter CpG islands of genes which may ...tyrosine phosphatase genemutated in human brain ,breast ,and prostate cancer[...
DNA Methylation ? Differentially methylated regions ...CpG sites outside of CpG islands ? Non-CpG methylated sites identified in human stem cells ?...
2006 ABSTRACT Methylation of CpG islands is ...The human myeloid leukemia cell lines THP-1, NB...(2006) Genome-Wide Profiling of CpG Methylation ...
Cancer cells present a global loss of DNA methylation centred in ...methylation events beyond classical promoter hypermethylation of CpG islands of ...
Hypermethylation of CpG islands also appears to be nonrandom. Thus, gene-...demonstrated methylation in at least one of the 14 colon cancer cell lines...
cation of DNA in human cells, and methylated ...Methylation of cytosines within CpG islands is ...cancer cells and indicates active transcription ...
DNA from the RKO colon cancer cell line (American Type Culture Collection,...Figure 2. A: Methylation analysis of CpG islands in ACF. Examples of ...
Cell Detection A Simple Model of Tag-Based Cooperation A Stochastic Method ...Methylation Status of CpG Islands in Human Genome Application of Color-...
热门文档